Scientific Reports · 2021 · 16 citations · 34 references
Life SciencesNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceSignal TransductionAmyotrophic Lateral SclerosisMotor Neuron DiseasesMuscle PhysiologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuromuscular ChangesAmyotrophic Lateral Sclerosis ModelsBody Mass ChangeMotor Neuron Disease ModelsMuscle AtrophySkeletal Muscle AtrophySkeletal Muscle DegenerationSkeletal Muscle PhysiologyTransgenic Mice
) 1Gur/J were used as the ALS model (n = 35), with wild-type B6SJL (WT) mice as controls (n = 7). ALS mice were analyzed before ALS onset, at ALS onset, and at terminal ALS. Levels of insulin/Akt signaling pathway proteins were determined, and the body and tibialis anterior muscle mass and plasma creatine kinase. Significantly increased levels of FOXO3a in ALS groups (from about 13 to 21-fold) compared to WT mice were observed. MuRF1 levels in the ONSET untrained group (12.0 ± 1.7 AU) were significantly higher than in WT mice (1.12 ± 0.2 AU) and in the BEFORE ALS group (3.7 ± 0.9 AU). This was associated with body mass and skeletal muscle mass reduction. Swim training significantly ameliorated the reduction of skeletal muscle mass in both TERMINAL groups (p < 0.001) and partially reversed changes in the levels of Akt signaling pathway proteins. These findings shed light on the swimming-induced attenuation of skeletal muscle atrophy in ALS with possible practical implications for anti-cachexia approaches.
34
B. Nave, D. Margriet Ouwens, Dominic J. Withers et al. · Biochemical Journal · 1999 · 923 citations · Full text